Evidence map›Paper›PMID 24073295›Full record

ArticleCurrent cardiovascular imaging reports2013

State of the Art in Cardiac Hybrid Technology: PET/MR.

Carmela Nappi, Georges El Fakhri

Abstract read
In one paragraph

Article in Current cardiovascular imaging reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Current uses and understanding of PET imaging in cardiac sarcoidosis.American journal of nuclear medicine and molecular imaging · 2024
    Review
  2. Synergistic motion compensation strategies for positron emission tomography when acquired simultaneously with magnetic resonance imaging.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2021
    Review
  3. Review
  4. Article
  5. Article
  6. Role of Cardiac PET in Clinical Practice.Current treatment options in cardiovascular medicine · 2017
    Review
  7. Review
  8. Article
  9. Intramyocardial hemorrhage: an enigma for cardiac MRI?BioMed research international · 2015
    Review
  10. Multimodality Imaging in Ischemic Cardiomyopathy.Current cardiovascular imaging reports · 2014
    Review
  11. Myocardial Inflammation-Are We There Yet?Current cardiovascular imaging reports
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Carmela NappiCenter for Advanced Medical Imaging Sciences, NMMI, Massachusetts General Hospital; Radiology Department, Harvard Medical School ; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy; SDN Foundation, Institute of Diagnostic and Nuclear Development, Naples, Italy.
Georges El Fakhri

Funding

Quantitative Oncologic PET-MRR01CA165221 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI EL FAKHRI, GEORGES · 2012 to 2023
$4.7M
Quantitative Cardiac PETR01HL110241 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI EL FAKHRI, GEORGES · 2011 to 2014
$1.9M
NCI NIH HHS R01 CA165221NHLBI NIH HHS R01 HL110241
6 · The paper itself

Abstract

Simultaneous PET/MRI is an emerging technique combining two powerful imaging modalities in a single device. The wide variety of available tracers for perfusion and metabolic studies and the high sensitivity of positron emission tomography (PET) combined with the high spatial resolution and soft tissue contrast of magnetic resonance imaging (MRI) in depicting cardiac morphology and function as well as MRI's absence of ionizing radiation makes PET/MRI very attractive to radiologists and clinicians. Nevertheless, PET/MR scientific and clinical promise is to be considered in the context of numerous technical challenges that hinder its use in the clinical setting. For example, in order for a PET system to work correctly within an MR field, major changes are required to the photon detection chain such as the elimination of photomultiplier tubes, etc. Another significant limitation of PET/MRI is the lack of an electron density map (as is the case with PET-CT) that can be readily obtained from MRI (the latter measures proton not electron density) and used to correct PET data for attenuation. Moreover, as with PET-CT, cardiac and respiratory motions cause image degradations that affect image quality and accuracy both in static and dynamic PET imaging. As a result, overcoming these (and other) technical limitations is a very active area of research both in academic institutions as well as industry. In this paper, we review recent literature on cardiac PET/MRI, present the state-of-the-art of this technology, and explore promising preclinical and clinical cardiac applications where PET/MRI could play a substantial role.

Indexed as

Cardiovascular diseaseCoronary artery diseaseHybrid PET/MRIIschemiaPET MRI

Identifiers

PMID24073295
PMCPMC3780420

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.